A near-haploid bone marrow karyotype in systemic mast cell disease: Is it characteristic of the disease or an incidental finding?

Cancer Genetics and Cytogenetics

Volumn 103, Issue 2, 1998, Pages 124-129

  Shekhter Levin, Sofia ^a,b   Ball, Edward ^b   Swerdlow, Steven H ^b   Li, W Victoria ^b   Kapadia, Silloo B ^b   Sherer, Maureen E ^a   Wald, Niel ^a   Gollin, Susanne M ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CHROMOSOME ANALYSIS; CYTOGENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MAST CELL; MASTOCYTOSIS; PRIORITY JOURNAL;

ADULT; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DISORDERS; FATAL OUTCOME; HAPLOIDY; HUMANS; KARYOTYPING; MALE; MASTOCYTOSIS; MOSAICISM;

EID: 0032104074     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00386-5     Document Type: Article

References (43)

1. Travis WD, Chin-Yang L (1993): Mast cell disease. In: The Mast Cell in Health and Disease. MA Kaliner, DD Metcalfe, eds. Marcel Dekker, Inc., New York, pp. 723-741.
2. Travis WD, Li C-Y, Bergstralh EJ, Yam LT, Gwee RG (1988): Systemic mast cell disease: analysis of 58 cases and literature review. Medicine 68:345-368.
3. Parwaresch RM, Horny HP, Bodewadt-Radzun S (1992): Mast cell disease. In: Neoplastic Hematopathology. DM Knowles, ed. Williams & Wilkins, Baltimore, pp. 1485-1515.
4. Fodinger M, Fritsch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, Valent P, Manhalter C (1994): Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood:2954-2959.
5. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD (1995): Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Nat Acad Sci USA 92:10,560-10,564.
6. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Landley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I (1996): Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312-314.
7. Yam LT, Yam C-F, Li CY (1978): Eosinophilia in systemic mastocytosis. Am J Clin Pathol 73:48-54.
8. Horton MA, O'Brien HAW (1983): Characterization of human mast cells in long-term culture. Blood 62:1251-1260.
9. Dalton R, Chan L, Batten E, Eridani S (1986): Mast cell leukemia: evidence for bone marrow origin of the pathological clone. Br J Haematol 64:397-406.
10. Swolin B, Rodjer S, Roupe G (1987): Cytogenetic studies in vitro colony growth in patients with mastocytosis. Blood 70:1928-1932.
11. Travis WD, Li C-Y, Yum LT, Bergstralh EJ, Swee RG (1988): Significance of systemic mast cell disease with associated hematologic disorders. Cancer 6:965-972.
12. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T (1987): Mast cell disease followed by leukemia with clonal evolution. Leukemia Res 11:769-773.
13. Zhang Y, Schlegelberger B, Weber-Matthiesen K, Grote W, Bartels H (1994): Translocation (X;8)((q2?;q21.3) in a case of systemic mastocytosis. Cancer Genet Cytogenet 78:236-238.
14. Travis WD, Li C-Y, Hoagland HC, Travis LB, Banks PM (1986): Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc 61:957-966.
15. Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988): Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 12:345-355.
16. Lishner M, Confino-Cohen R, Mekori YA, Feigin M, Manor Y, Goldberg A, Ravid M, Amiel A (1996): Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol 98:199-204.
17. Bauchinger M, Mezger J (1990): A case of malignant mastocytosis with near-haploid, near-diploid, and polyploid cells in the bone marrow. Cancer Genet Cytogenet 48:13-21.
18. Li WV, Kapadia SB, Sonmez-Alpan E, Swerdlow SH (1996): Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase. CD68, myeloperoxidase, lysozyme and CD20 antibodies. Mod Pathol 9:982-988.
19. Sherer ME, Shekhter-Levin S, Krause JR, Joyce RA, Gollin SM (1991): Atypical (7;19) translocation in acute myelomonocytic leukemia. Cancer Genet Cytogenet 57:169-173.
20. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
21. Kessous A, Corberand J, Grozdea J, Colombies P (1975): Clone cellulaire a 27 chromosomes dan une leucemic: Aigue humaine. Nouv Rev Fr Hematol 15:73-82.
22. Oshimura M, Freeman AI, Sandberg A (1977): Chromosomes and causation of human cancer and leukemia XXIII: nearhaploidy in acute leukemia. Cancer 40:1143-1148.
23. Kaneko Y, Sakurai M (1980): Acute leukemia (ALL) with nearhaploidy: a unique subgroup of ALL? Cancer Genet Cytogenet 2:13-18.
24. Kohno S-I, Minowada J, Sandberg AA (1980): Chromosome evolution of near-haploid clones in an established human acute lymphoblastic leukemia cell line (NALM-16). J Natl Cancer Inst 64:485-493.
25. Gallen DF, Raphael K, Michael PM, Garson OM (1989): Acute lymphoblastic leukemia with a hypodiploid karyotype with less than 40 chromosomes: the basis for division into two subgroups. Leukemia 3:749-752.
26. Redner A, Hegewisch S, Haimi J, Steinherz P, Jhanwar S, Andreeff M (1990): A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia. Leukemia Res 14:771-777.
27. Pui C-H, Carrol AJ, Raimondi SC, Land VJ, Grist WM, Shuster JJ, Williams DL, Pullen DJ, Borowitz MJ, Behm FG, Look T (1990): Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid <45 line. Blood 75:1170-1177.
28. Gibbons B, MacCallum P, Watts E, Rohatiner AZS, Webb D, Katz FE, Seeker-Walker LM, Temperley IJ, Harrison CJ, Campbell RHA, Broadbent V, Chessells JM (1991): Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature. Leukemia 5:738-743.
29. Bice G, O'Malley D, Storto P (1994): Near-haploidy: cytogenetic guidelines for the detection of an under-reported subgroup of acute lymphoblastic leukemia. Appl Cytogenet 20:159-162.
30. Daniel A, Francis SE, Stewart LA, Barber S (1978): A nearhaploid clone: 24,XY,t(9;22)(q34;qll) from a patient in blast crisis of chronic myeloid leukemia. Scand J Haematol 21:99-103.
31. Hartley SE, Cook MK (1979): Near-haploidy in a case of chronic myeloid leukemia. Cancer Genet Cytogenet 1:169-176.
32. Kessous A, Colombies P, Pris J, Clement D (1980): Near haploid cell line in lymphoid blast crisis of Ph-positive chronic myeloid leukemia. Cancer Res 40:1354-1359.
33. Ishihara T, Minamihisamatsu M, Kohno S-I (1982): Near-haploid conversion in Ph1-positive chronic myelocytic leukemia. Proc Jpn Acad 58:165-168.
34. Najafzadeh TM, Dumars GE, Dumars KW, Simpkins H, Katz J (1983): Near-haploid cell line in the blastic crisis of chronic myelogenous leukemia: a possible marker for lymphoid malignancy. Cancer Genet Cytogenet 8:333-339.
35. Kristoffersson U, Olsson H, Kelly D, Akerman M, Mitelman F (1986): Near-haploidy in a case of plasmocytoma. Cancer Genet Cytogenet 19:239-243.
36. Pan SF, Sherer CR, Ellis LD, Wald N (1981): Near haploidy in chronic myelogenous leukemia. Mamm Chromosom Newslett 22:143-146.
37. Andersson BS, Beran M, Pathak S, Goodacre A, Barlogie B, McCredie KB (1987): Ph-positive chronic myeloid leukemia with near-haploid conversion in vivo and establishment of a continuously growing cell line with similar cytogenetic pattern. Cancer Genet Cytogenet 24:335-343.
38. Mayne KM, Maher EJ (1989): Near-haploid cell line in megakaryoblastic transformation of Philadelphia-positive chronic myeloid leukemia. Cancer Genet Cytogenet 39:133-136.
39. Sandberg AA (1990): The Chromosomes in Human Cancer and Leukemia, ed 2, Elsevier, New York, pp. 355-356.
40. Chang F, Syrjanen S, Syrjanen K (1995): Implication of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 13:1009-1022.
41. Cline MJ (1994). The molecular basis of leukemia. New Engl J Med 330:328-336.
42. Horny HP, Kaiserling E, Griesser GH (1993): Human mast cells in cases of cutaneous, systemic and malignant mastocytosis do not show immunohistochemically detectable overexpression of p53 protein. Br J Haematol 83:524-525.
43. Vanderbark GR, deCastro CM, Taylor H, Dew-Knight S, Kaufman RE (1992): Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259-1266.